SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018338
Filing Date
2024-05-09
Accepted
2024-05-09 08:30:44
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 627820
2 ex31-1.htm EX-31.1 17575
3 ex31-2.htm EX-31.2 17956
4 ex32-1.htm EX-32.1 6890
5 ex32-2.htm EX-32.2 6815
  Complete submission text file 0001493152-24-018338.txt   3522938

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE thar-20240331.xsd EX-101.SCH 23896
7 XBRL CALCULATION FILE thar-20240331_cal.xml EX-101.CAL 25223
8 XBRL DEFINITION FILE thar-20240331_def.xml EX-101.DEF 103170
9 XBRL LABEL FILE thar-20240331_lab.xml EX-101.LAB 275319
10 XBRL PRESENTATION FILE thar-20240331_pre.xml EX-101.PRE 211071
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 452956
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41210 | Film No.: 24928749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)